Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-067118

Director acquired 611,224 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Menzel Garry E · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2023-06-01 Grant or award : show line 1 in the form +200,646 200,646 I
2023-06-01 Grant or award : show line 2 in the form +200,647 200,647 I
2023-06-01 Grant or award : show line 3 in the form +209,931 209,931 D
Loading xslF345X04/tm2317417-4_4.xml…